Ozempic 1mg Injection is a prescription medicine that belongs to a class called GLP-1 receptor agonists. It works in a way similar to a natural hormone in the body that... Read More
Author: altusskincare
Ozempic 0.5mg Injection is a prescription medicine that belongs to a class called GLP-1 receptor agonists. It works in a way similar to a natural hormone in the body that... Read More
Ozempic 0.25mg Injection is a prescription medicine that belongs to a class called GLP-1 receptor agonists. It works in a way similar to a natural hormone in the body that... Read More
Aromasin is the brand name for Exemestane, a potent oral medication classified under aromatase inhibitors (AIs). Specifically developed for postmenopausal women with estrogen-receptor-positive breast cancer, Aromasin plays a critical role... Read More
Decapeptyl Injection has emerged as a highly trusted and effective treatment in the management of hormone-sensitive conditions, including advanced prostate cancer, endometriosis, uterine fibroids, and infertility. With its powerful formulation... Read More
Bortezomib, marketed under the brand name Bortenat Injection, Myezom Injection, Cabapan Injection and others, represents a significant therapeutic advancement in the management of hematologic cancers. It is a reversible proteasome... Read More
Abiraterone Tablets, marketed under brand names such as Zytiga® and widely available as generic abiraterone acetate, represent a major leap forward in the management of advanced prostate cancer. Approved by... Read More
It comes packaged as hard gelatin capsules in varying strengths—2.5 mg up to 25 mg—for oral use. Widely known by its brand name Lenalid, it is identified on the WHO’s... Read More
Carfilnat Injection is a concentrated injectable formulation of Carfilzomib, a second-generation proteasome inhibitor specifically indicated for the treatment of relapsed and refractory multiple myeloma. Developed with a deep understanding of... Read More
Gefitinib, commercially known by brand names such as Gefttinat Table, is a first-generation EGFR tyrosine kinase inhibitor (EGFR-TKI). It is primarily used to treat non-small cell lung cancer (NSCLC) that... Read More